The Ethical Use of Placebo in Clinical Trials Involving Children
- 1 June 2004
- journal article
- Published by Mary Ann Liebert Inc in Journal of Child and Adolescent Psychopharmacology
- Vol. 14 (2) , 169-174
- https://doi.org/10.1089/1044546041649057
Abstract
The authors reviewed various statements describing the ethical use of placebo-controls in clinical trials involving minors. Attention was focused upon the Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric Populations, published by the American Academy of Pediatrics (AAP) (Kaufman et al. 1995). A brief review of certain key documents and a possible expansion of the guidelines are presented. Specifically, it is recommended that a review and update of guidelines for the use of placebo-controlled trials in children be undertaken by a working group comprised of stakeholders, including academic clinical and research professionals, bioethicists, consumers, members of key government agencies, and the pharmaceutical industry.Keywords
This publication has 6 references indexed in Scilit:
- Ethical issues in research and innovative therapy in children with mood disordersBiological Psychiatry, 2001
- Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 1: Ethical and Scientific IssuesAnnals of Internal Medicine, 2000
- Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 2: Practical Issues and Specific CasesAnnals of Internal Medicine, 2000
- A Review of Pharmacotherapy of Major Depression in Children and AdolescentsPsychiatric Services, 2000
- Symptom Reduction and Suicide Risk in Patients Treated With Placebo in Antidepressant Clinical TrialsArchives of General Psychiatry, 2000
- Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric PopulationsPediatrics, 1995